An Algorithm Using Botox Injections for Facial Scar Improvement in Fitzpatrick Type IV-VI Skin

Debraj Shome, Stuti Khare, Rinky Kapoor, Debraj Shome, Stuti Khare, Rinky Kapoor

Abstract

Background: Wounds of the face are known to heal poorly with conspicuous scarring. Hence, it is crucial to address the distracting effect of muscle pull on immature collagen, which often leads to worsening of scars.

Study design: Prospective clinical study.

Methods: One hundred patients with a minimum of 6 months follow-up were recruited. All patients with depressed scars underwent surgery for scar revision. Two weeks before surgical intervention, intramuscular Botulinum toxin was injected around the scar, to prevent movement of the facial muscles. From the second week postsurgery, Cicatrix (Formulation containing activated Centella Asiatica & Pinus Sylvestris, Catalysis, Spain) was routinely used, 3 times a day, for 6 months post the scar revision surgery. Six weeks postsurgery, Fractional C02 laser treatment was started and performed every 4 weeks.

Results: Using the Objective Assessment Score and the Subjective Assessment Score, the mean of the scores were taken. All patients had satisfactory results, as measured by a patient satisfaction survey and objectively by the physician assessment.

Discussion: Botulinum toxin injected before scar revision surgery resulted in the wound being stabilized, better wound healing, and prevention of wound widening during healing.

Conclusion: In view of the results of this study, it is considered worthwhile to offer patients with facial scars, Botulinum toxin injections before scar revision surgery, followed by Fractional C02 laser, along with the routine use of Cicatrix Cream.

Figures

Fig. 1.
Fig. 1.
Showing before image of patient 1, with the facial scar caused due to burns.
Fig. 2.
Fig. 2.
Showing after image of patient 1, on whom scar revision surgery was performed for the facial scar caused due to burns. Results after 8 sessions of FCO2 laser. Photographs pre and post, taken 12 months apart.
Fig. 3.
Fig. 3.
Showing before image of patient 2.
Fig. 4.
Fig. 4.
Showing after image of patient 2, on whom scar revision surgery was performed. Results after 6 sessions of FC02 laser. Photographs pre and post, taken 9 months apart.
Fig. 5.
Fig. 5.
Showing before image of patient 3.
Fig. 6.
Fig. 6.
Showing after image of patient 3, on whom scar revision surgery was performed. Results after 7 sessions of FC02 laser. Photographs pre and post, taken 12 months apart.
Fig. 7.
Fig. 7.
Showing before image of patient 4.
Fig. 8.
Fig. 8.
Showing after image of patient 4, on whom scar revision surgery was performed. Results after 8 sessions of FC02 laser. Photographs pre and post, taken 15 months apart.
Fig. 9.
Fig. 9.
Showing before image of patient 5.
Fig. 10.
Fig. 10.
Showing after image of patient 5, on whom scar revision surgery was performed. Results after 8 session of FCO2 laser. Photographs pre and post, taken 18 months apart.
Fig. 11.
Fig. 11.
Showing before image of the patient 6, who suffered facial trauma due to road traffic accident.
Fig. 12.
Fig. 12.
Showing after image of patient 6, after 8 sessions of FCO2 laser. Photograph taken 18 months later.

References

    1. Wall SA, Chait LA, Temlett JA, et al. Botulinum A chemodenervation: a new modality in cerebral palsied hands. Br J Plast Surg. 1993;46:703.
    1. Wilson AM. Use of botulinum toxin type A to prevent widening of facial scars. Plast Reconstr Surg. 2006;117:1758; discussion 1767.
    1. Shaari CM, Sanders I, Wu BL, et al. Rhinorrhea is decreased in dogs after nasal application of botulinum toxin. Otolaryngol Head Neck Surg. 1995;112:566.
    1. Keen M, Blitzer A, Aviv J, et al. Botulinum toxin A for hyperkinetic facial lines: results of a double-blind, placebo-controlled study. Plast Reconstr Surg. 1994;94:94.
    1. Goodman GJ. The use of botulinum toxin as primary or adjunctive treatment for post acne and traumatic scarring. J Cutan Aesthet Surg. 2010;3:90.
    1. Kapoor R, Shome D, Jain V, et al. Facial rejuvenation post intradermal Botulinum toxin: is it really the Botox or is it the prick. Dermatol Surg. 2010;4:2106.
    1. Carruthers JD, Carruthers JA. Treatment of glabellar frown lines with C. botulinum-A exotoxin. J Dermatol Surg Oncol. 1992;18:17.
    1. Kwok T, Tao J. A practical approach to classification and treatment of scars. STL FP. 2011;7:60.
    1. Goodman G. Botulinum toxin for the correction of hyperkinetic facial lines. Australas J Dermatol. 1998;39:158.
    1. Coleman KR, Carruthers J. Combination therapy with BOTOX and fillers: the new rejuvnation paradigm. Dermatol Ther. 2006;19:177.
    1. Lee BJ, Jeong JH, Wang SG, et al. Effect of botulinum toxin type a on a rat surgical wound model. Clin Exp Otorhinolaryngol. 2009;2:20.
    1. Gassner HG, Sherris DA, Otley CC. Treatment of facial wounds with botulinum toxin A improves cosmetic outcome in primates. Plast Reconstr Surg. 2000;105:1948.
    1. Gassner HG, Sherris DA, Friedman O. Botulinum toxin-induced immobilization of lower facial wounds. Arch Facial Plast Surg. 2009;11:140.
    1. Sahinkanat T, Ozkan KU, Ciralik H, et al. Botulinum toxin-A to improve urethral wound healing: an experimental study in a rat model. Urology. 2009;73:405.
    1. Zhibo X, Miaobo Z. Botulinum toxin type A affects cell cycle distribution of fibroblasts derived from hypertrophic scar. J Plast Reconstr Aesthet Surg. 2008;61:1128.
    1. Arora D, Kumar M, Dubey SD. Centella asiatica—a review of its medicinal uses & pharmacological effects. J Nat Remedies. 2002;5:5143.
    1. Seevaratnam V, Banumathi P, Premalatha MR, et al. Functional properties of Centella asiatica. Int J Pharm Pharm Sci. 2012;4:8.
    1. Romo EM, Fundora FP, Albakes CR, et al. The effectiveness of cream with Centella Asiatica and Pinus Sylvestris to treat scars and burns. Clinical trail. Dermatologia Kliniczna. 2012;14:3.
    1. Ross EV, Barnette DJ, Glatter RD, et al. Effects of overlap and pass number in CO2 laser skin resurfacing: a study of residual thermal damage, cell death, and wound healing. Lasers Surg Med. 1999;24:103.

Source: PubMed

3
Iratkozz fel